Vimal Elaichi makers move Delhi HC over FDA notices to Shah Rukh Khan, Ajay Devgn, Tiger Shroff
By United One News · AI-generated summary of 3 outlets' reporting
Published · Updated
AI-generated summary of the coverage listed below: Vimal Elaichi producers have taken legal action in the Delhi High Court challenging Maharashtra Food and Drug Administration notices that allege the actors Shah Rukh Khan, Ajay Devgn and Tiger Shroff used the product in a way that could be considered surrogate advertising. The case centers on jurisdictional disputes and the interpretation of advertising regulations, and it could set a precedent for how celebrity endorsements are regulated in India.
Covered by 3 outlets across the spectrum: 0% left, 67% center, 33% right.
How each side framed it
Vimal Elaichi Ad Case: Delhi HC Reserves Verdict On Plea Against Notices To Shah Rukh Khan, Ajay Devgn, Tiger Shroff
Vimal Elaichi Makers Move Delhi HC Against Maharashtra FDA Notices To Shah Rukh, Ajay, Tiger
Left-leaning outlets have under-covered this story. Of 3 outlets, only 0 are on the left of the spectrum.
Timeline
First reported by The New Indian Express on ; 3 articles from 3 outlets so far.
Who is covering this story
- Center (2): The New Indian Express, ABP Live English
- Right-leaning (1): Times Now
Sources
- Vimal Elaichi makers move Delhi HC over FDA notices to Shah Rukh Khan, Ajay Devgn, Tiger Shroff — The New Indian Express (center) ·
- Vimal Elaichi Makers Move Delhi HC Against Maharashtra FDA Notices To Shah Rukh, Ajay, Tiger — Times Now (right-leaning) ·
- Vimal Elaichi Ad Case: Delhi HC Reserves Verdict On Plea Against Notices To Shah Rukh Khan, Ajay Devgn, Tiger Shroff — ABP Live English (center) ·